MedPath

Efficacy of switching to 0.1% Brimonidine Tartrate in glaucoma patients under combined theraphy.

Not Applicable
Conditions
glaucoma
Registration Number
JPRN-UMIN000010978
Lead Sponsor
Department of Ophthalmology, Yamagata University Medical Hospital.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
32
Inclusion Criteria

Not provided

Exclusion Criteria

Glaucoma patient that it is determined effect is sufficient clinically in the treatment of current.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Target 32 eye 19 cases glaucome patients during the period April 2013 from June 2012, to perform the treatment combination multidrug in Yamagata University Medical Hospital ophthalmology hospital was also determined effect is insufficient clinically. Were compared before and after the switch to 0.1% brimonidine tartrate ophthalmic solution 1 agents already in use without providing the washout period, the switching effect lowering IOP.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath